237 related articles for article (PubMed ID: 15221969)
21. Prognostic implications of routine, immunohistochemical, and molecular staging in resectable pancreatic adenocarcinoma.
Niedergethmann M; Rexin M; Hildenbrand R; Knob S; Sturm JW; Richter A; Post S
Am J Surg Pathol; 2002 Dec; 26(12):1578-87. PubMed ID: 12459624
[TBL] [Abstract][Full Text] [Related]
22. Sensitive detection of K-ras mutations augments diagnosis of colorectal cancer metastases in the liver.
Schimanski CC; Linnemann U; Berger MR
Cancer Res; 1999 Oct; 59(20):5169-75. PubMed ID: 10537293
[TBL] [Abstract][Full Text] [Related]
23. Mutation pattern of K-ras gene in colorectal cancer patients of Kashmir: a report.
Sameer AS; Chowdhri NA; Abdullah S; Shah ZA; Siddiqi MA
Indian J Cancer; 2009; 46(3):219-25. PubMed ID: 19574674
[TBL] [Abstract][Full Text] [Related]
24. One hundred consecutive cases of sentinel lymph node mapping in early colorectal carcinoma: detection of missed micrometastases.
Wood TF; Nora DT; Morton DL; Turner RR; Rangel D; Hutchinson W; Bilchik AJ
J Gastrointest Surg; 2002; 6(3):322-9; discussion 229-30. PubMed ID: 12022982
[TBL] [Abstract][Full Text] [Related]
25. Modified mismatch polymerase chain reaction-restriction fragment length polymorphism detected mutations in codon 12 and 13 of exon 2 of K-
Faleel FD; Zoysa MI; Lokuhetti MD; Gunawardena YI; Chandrasekharan VN; Dassanayake RS
J Cancer Res Ther; 2016; 12(4):1272-1277. PubMed ID: 28169239
[TBL] [Abstract][Full Text] [Related]
26. Ex vivo sentinel lymph node mapping in colon cancer: improving the accuracy of pathologic staging?
Smith J; Hwang H; Wiseman KW; Filipenko D; Phang PT
Am J Surg; 2006 May; 191(5):665-8. PubMed ID: 16647356
[TBL] [Abstract][Full Text] [Related]
27. [Mapping the sentinel lymph node ex vivo and finding the micrometastasis by CK-immunostaining in carcinoma of the colon and rectum].
Wang FL; Pan ZZ; Wan DS
Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):994-7. PubMed ID: 16194357
[TBL] [Abstract][Full Text] [Related]
28. Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality.
Al-Mulla F; Going JJ; Sowden ET; Winter A; Pickford IR; Birnie GD
J Pathol; 1998 Jun; 185(2):130-8. PubMed ID: 9713338
[TBL] [Abstract][Full Text] [Related]
29. Detection of isolated tumor cells by polymerase chain reaction-restriction fragment length polymorphism for K-ras mutations in tissue samples of 199 colorectal cancer patients.
Dieterle CP; Conzelmann M; Linnemann U; Berger MR
Clin Cancer Res; 2004 Jan; 10(2):641-50. PubMed ID: 14760087
[TBL] [Abstract][Full Text] [Related]
30. Detection of infrequent and multiple K-ras mutations in human tumors and tumor-adjacent tissues.
Keohavong P; Zhu D; Whiteside TL; Swalsky P; Bakker A; Elder EM; Siegfried JM; Srivastava S; Finkelstein SD
Anal Biochem; 1997 May; 247(2):394-403. PubMed ID: 9177704
[TBL] [Abstract][Full Text] [Related]
31. Detection of K-ras mutations in DNAs isolated from feces of patients with colorectal tumors by mutant-allele-specific amplification (MASA).
Hasegawa Y; Takeda S; Ichii S; Koizumi K; Maruyama M; Fujii A; Ohta H; Nakajima T; Okuda M; Baba S
Oncogene; 1995 Apr; 10(7):1441-5. PubMed ID: 7731696
[TBL] [Abstract][Full Text] [Related]
32. Limitations in molecular detection of lymph node micrometastasis from colorectal cancer.
Klebig F; Fischer C; Petri S; Gerull H; Wagener C; Tschentscher P
Diagn Mol Pathol; 2007 Jun; 16(2):91-5. PubMed ID: 17525678
[TBL] [Abstract][Full Text] [Related]
33. Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype.
Bazan V; Migliavacca M; Zanna I; Tubiolo C; Grassi N; Latteri MA; La Farina M; Albanese I; Dardanoni G; Salerno S; Tomasino RM; Labianca R; Gebbia N; Russo A
Ann Oncol; 2002 Sep; 13(9):1438-46. PubMed ID: 12196370
[TBL] [Abstract][Full Text] [Related]
34. Fast simultaneous detection of K-RAS mutations in colorectal cancer.
Chang YS; Yeh KT; Chang TJ; Chai C; Lu HC; Hsu NC; Chang JG
BMC Cancer; 2009 Jun; 9():179. PubMed ID: 19515263
[TBL] [Abstract][Full Text] [Related]
35. Genetic diagnosis of lymph-node metastasis in colorectal cancer.
Hayashi N; Ito I; Yanagisawa A; Kato Y; Nakamori S; Imaoka S; Watanabe H; Ogawa M; Nakamura Y
Lancet; 1995 May; 345(8960):1257-9. PubMed ID: 7746054
[TBL] [Abstract][Full Text] [Related]
36. Validation of ex vivo lymphatic mapping in hematoxylin-eosin node-negative carcinoma of the colon and rectum.
Wong JH; Johnson DS; Namiki T; Tauchi-Nishi P
Ann Surg Oncol; 2004 Aug; 11(8):772-7. PubMed ID: 15249341
[TBL] [Abstract][Full Text] [Related]
37. Discordance between K-ras mutations in bone marrow micrometastases and the primary tumor in colorectal cancer.
Tórtola S; Steinert R; Hantschick M; Peinado MA; Gastinger I; Stosiek P; Lippert H; Schlegel W; Reymond MA
J Clin Oncol; 2001 Jun; 19(11):2837-43. PubMed ID: 11387355
[TBL] [Abstract][Full Text] [Related]
38. Genetic diagnosis identifies occult lymph node metastases undetectable by the histopathological method.
Hayashi N; Arakawa H; Nagase H; Yanagisawa A; Kato Y; Ohta H; Takano S; Ogawa M; Nakamura Y
Cancer Res; 1994 Jul; 54(14):3853-6. PubMed ID: 8033106
[TBL] [Abstract][Full Text] [Related]
39. Polymerase chain reaction/sequencing analysis of ras mutations in paraffin-embedded tissues as compared with 3T3 transfection and polymerase chain reaction/sequencing of frozen tumor deoxyribonucleic acids.
Goodrow TL; Prahalada SR; Storer RD; Manam SV; Leander KR; Kraynak AR; van Zwieten MJ; Nichols WW; Bradley MO
Lab Invest; 1992 Apr; 66(4):504-11. PubMed ID: 1583889
[TBL] [Abstract][Full Text] [Related]
40. Detection of occult metastases in lymph nodes from patients with colorectal carcinoma by reverse transcriptase-polymerase chain reaction.
Liu Z; Ye X; Bi W; Wang M; Li Y; Chen T
Chin Med J (Engl); 2002 Apr; 115(4):529-31. PubMed ID: 12133290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]